Christian Plank

Company: Ethris

Job title: Chief Technology Officer

Seminars:

Panel Discussion: Overviewing the Greatest Risks Posed by Lipid Nanoparticles to Mitigate Adverse Affect Occurence 2:30 pm

Sharing insights into the adverse affects recorded across the literature and triaging the common causes of such events Spotlighting steps of formulation which require greatest attention to control the toxicity profile of the LNP Considering bioaccumulation of LNPs and the types of therapeutics and target sites which increase this riskRead more

day: Conference Day One

Exploring the Vast Array of Lipids for LNP Formulation with Insights into Lipid Characterisation to Optimise Drug Delivery 8:30 am

Revealing the impact of lipid components on LNP size, structure, stability, PKa, encapsulation efficiency and endosomal release Unravelling the crucial roles of ionisable cationic lipids in LNP encapsulation and subsequent endosomal release Employing sophisticated screening techniques to create a comprehensive lipid profile, reducing the risk of LNP instability and impuritiesRead more

day: Conference Day One